Literature DB >> 20953573

[Topical tacrolimus in necrobiosis lipoidica].

D Barth1, W Harth, R Treudler, J C Simon.   

Abstract

Necrobiosis lipoidica (NL) is a chronic inflammatory skin disease that is difficult to treat. The etiology is unknown, but vascular abnormalities and immunologic factors have been implicated. We treated a patient with long-standing NL with multiple vascular risk factors (diabetes mellitus, protein S-deficiency, and antiphospholipid syndrome) with topical tacrolimus, a non-steroidal immunomodulator that causes no skin atrophy. After 12 weeks of topical tacrolimus (0.1%) ointment, our patient already showed a good remission with a significant decrease in inflammatory signs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20953573     DOI: 10.1007/s00105-010-2058-9

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  13 in total

1.  Topical tacrolimus in granuloma annulare and necrobiosis lipoidica.

Authors:  W Harth; R Linse
Journal:  Br J Dermatol       Date:  2004-04       Impact factor: 9.302

2.  Successful treatment of chronic ulcerated necrobiosis lipoidica with 0.1% topical tacrolimus ointment.

Authors:  T H Clayton; P V Harrison
Journal:  Br J Dermatol       Date:  2005-03       Impact factor: 9.302

3.  Tacrolimus 0.1% and granuloma annulare: description of three cases.

Authors:  T Grieco; C Cantisani; P Faina; F Cantoresi; F Lacobellis; E Silvestri; V Faina; S Calvieri
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-03-11       Impact factor: 6.166

4.  Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome.

Authors:  A Allen; E Siegfried; R Silverman; M L Williams; P M Elias; S K Szabo; N J Korman
Journal:  Arch Dermatol       Date:  2001-06

5.  Ulcerated necrobiosis lipoidica: a combined treatment approach with dermatosurgery and PUVA.

Authors:  Erich Köstler; Uwe Wollina
Journal:  Int J Low Extrem Wounds       Date:  2003-12       Impact factor: 2.057

Review 6.  Manifestations of cutaneous diabetic microangiopathy.

Authors:  Binh T Ngo; Kristie D Hayes; Dominick J DiMiao; Shashi K Srinivasan; Christopher J Huerter; Marc S Rendell
Journal:  Am J Clin Dermatol       Date:  2005       Impact factor: 7.403

7.  Squamous cell carcinoma arising in long-standing necrobiosis lipoidica.

Authors:  J Santos-Juanes; C Galache; J R Curto; M P Carrasco; A Ribas; J Sánchez del Río
Journal:  J Eur Acad Dermatol Venereol       Date:  2004-03       Impact factor: 6.166

8.  Necrobiosis lipoidica: ultrastructural and biochemical demonstration of a collagen defect.

Authors:  A Oikarinen; M Mörtenhumer; M Kallioinen; E R Savolainen
Journal:  J Invest Dermatol       Date:  1987-02       Impact factor: 8.551

Review 9.  Assigning new roles to topical tacrolimus.

Authors:  Eustathios Rallis; Chrysovalantis Korfitis; Stamatis Gregoriou; Dimitris Rigopoulos
Journal:  Expert Opin Investig Drugs       Date:  2007-08       Impact factor: 6.206

10.  Healing of chronic necrobiosis lipoidica lesions in a type 1 diabetic patient after pancreas-kidney transplantation: a case report.

Authors:  D Gullo; A Latina; L Tomaselli; M L Arpi; S Squatrito; S Curatolo; S La Greca; R Vigneri
Journal:  J Endocrinol Invest       Date:  2007-03       Impact factor: 4.256

View more
  3 in total

1.  Ulcerated necrobiosis lipoidica as a rare cause for chronic leg ulcers: case report series of ten patients.

Authors:  Cindy Franklin; Maren Stoffels-Weindorf; Uwe Hillen; Joachim Dissemond
Journal:  Int Wound J       Date:  2013-10-07       Impact factor: 3.315

2.  Necrobiosis lipoidica: early diagnosis and treatment with tacrolimus.

Authors:  A Patsatsi; A Kyriakou; D Sotiriadis
Journal:  Case Rep Dermatol       Date:  2011-04-18

Review 3.  Treatment Modalities of Necrobiosis Lipoidica: A Concise Systematic Review.

Authors:  Amir Feily; Shadi Mehraban
Journal:  Dermatol Reports       Date:  2015-06-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.